Xarelto uncontrolled bleeding trigger lawsuits

Lawsuits filed against the makers of Xarelto have surpassed 4,500 since the drug was approved by the U.S. Food and Drug Administration (FDA) in 2011.

Xarelto was approved by FDA for patients recovering from knee and hip replacement surgeries, as well as patients who are at a greater risk of stroke due to atrial fibrillation, and those suffering from deep vein thrombosis or pulmonary embolism. The drug was suppose to be a game-changing new type of blood thinner that could provide patients receiving the drug new freedoms not available with other blood thinners.

Lawsuits filed against the makers of Xarelto allege that the drug causes uncontrolled and/or excessive bleeding.

In one such case, the plaintiff is requesting for $4.35 million settlement. The plaintiff claims that the anticoagulant drug caused him to experience an uncontrolled and sudden bleeding episode.

This lawsuit is significant because it involves 90-counts and requests a large compensation. According to documents from the lawsuit, the plaintiff argues that the makers of Xarelto used misleading tactics to market the blood thinner as a safe and effective medication for people seeking to reduce their stroke risk. Furthermore, the plaintiff argues that the makers of Xarelto failed to sufficiently warn consumers of possible fatal side effects that the plaintiff believes can be caused by the drug.

The plaintiff argues the makers of Xarelto may have been aware that he drug could cause an increased risk of sudden bleeding episodes among patients taking the blood thinner. The plaintiff points to clinical studies conducted on Xarelto to support his argument.

Bellwether trials are expected to start February 2017. However, if you or a person you know suffered from injuries caused by Xarelto, don’t hesitate to reach out to us. Our office handles Xarelto cases across the United States.